Ciprofloxacin vs Etomidate
Mechanistic comparison of Ciprofloxacin and Etomidate Imidazole derivative anesthetic and hypnotic with little effect on blood gases based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
15
Shared Targets
65%
Jaccard Similarity
68%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Evidence Comparison
Target Overlap
Ciprofloxacin and Etomidate share 15 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.652 means 65% of the combined target set is bound by both compounds. The IDF-weighted score of 0.684 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.